Granules India gets Health Canada nod to market arthritis tablets

Drug firm Granules India on Monday said it has received marketing nod from Health Canada for its Acetaminophen extended-release tablets used in the treatment of arthritis pain. The company has received approval from Health Canada for Acetaminophen extended-release tablets OTC, 650 mg, Granules India said in a regulatory filing.

“We received the approval within eight months of filing. This is a step towards global expansion of our core molecules. The approval of Acetaminophen extended-release tablets OTC, 650mg…, is a good addition to our portfolio,” Granules USA, Inc & Granules Pharmaceuticals, Inc Executive Director Priyanka Chigurupati said.

The company will be launching the product in Canadian market soon, she added.

The drug will be manufactured at the company’s manufacturing facility located in GagillapurHyderabad, the filing said.

Shares of Granules India Ltd were trading at Rs 335.90 per scrip on BSE, up 1.53 per cent from its previous close.

  • Related Posts

    UKHSA and University of Oxford scientists uncover genetic changes in the bacteria causing severe Kent meningococcal disease outbreak

    Scientists from UKHSA, the University of Oxford and a collaboration of academic institutions have used bacterial genome sequencing to understand why the meningococcal disease outbreak in Kent earlier this year…

    ‘Broad daylight dacoity’, says Supreme Court on overpricing of essential cancer drugs

    ‘It is very surprising that the authorities who are supposed to take action on this are silent,’ says Bench Terming it a “broad daylight dacoity” against patients, the Supreme Court…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    UKHSA and University of Oxford scientists uncover genetic changes in the bacteria causing severe Kent meningococcal disease outbreak

    UKHSA and University of Oxford scientists uncover genetic changes in the bacteria causing severe Kent meningococcal disease outbreak

    ‘Broad daylight dacoity’, says Supreme Court on overpricing of essential cancer drugs

    ‘Broad daylight dacoity’, says Supreme Court on overpricing of essential cancer drugs

    CDSCO finds one spurious drug sample in Delhi, 220 NSQs in Aug surveillance

    CDSCO finds one spurious drug sample in Delhi, 220 NSQs in Aug surveillance

    FSDA cancels 16 pharmacy licences, suspends 8, including Pfizer depot

    FSDA cancels 16 pharmacy licences, suspends 8, including Pfizer depot

    Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

    Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

    WHO launches new primary health care course to strengthen health systems globally

    WHO launches new primary health care course to strengthen health systems globally